Wave Life Sciences (WVE) Competitors $13.67 -1.33 (-8.87%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends WVE vs. AKBA, URGN, RAPT, MRNS, CRNX, ASND, LEGN, ELAN, VKTX, and CYTKShould you be buying Wave Life Sciences stock or one of its competitors? The main competitors of Wave Life Sciences include Akebia Therapeutics (AKBA), UroGen Pharma (URGN), RAPT Therapeutics (RAPT), Marinus Pharmaceuticals (MRNS), Crinetics Pharmaceuticals (CRNX), Ascendis Pharma A/S (ASND), Legend Biotech (LEGN), Elanco Animal Health (ELAN), Viking Therapeutics (VKTX), and Cytokinetics (CYTK). These companies are all part of the "pharmaceutical products" industry. Wave Life Sciences vs. Akebia Therapeutics UroGen Pharma RAPT Therapeutics Marinus Pharmaceuticals Crinetics Pharmaceuticals Ascendis Pharma A/S Legend Biotech Elanco Animal Health Viking Therapeutics Cytokinetics Akebia Therapeutics (NASDAQ:AKBA) and Wave Life Sciences (NASDAQ:WVE) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, community ranking, risk, media sentiment, profitability, valuation and institutional ownership. Does the MarketBeat Community believe in AKBA or WVE? Akebia Therapeutics received 52 more outperform votes than Wave Life Sciences when rated by MarketBeat users. However, 67.79% of users gave Wave Life Sciences an outperform vote while only 64.09% of users gave Akebia Therapeutics an outperform vote. CompanyUnderperformOutperformAkebia TherapeuticsOutperform Votes41464.09% Underperform Votes23235.91% Wave Life SciencesOutperform Votes36267.79% Underperform Votes17232.21% Do insiders & institutionals have more ownership in AKBA or WVE? 33.9% of Akebia Therapeutics shares are held by institutional investors. Comparatively, 89.7% of Wave Life Sciences shares are held by institutional investors. 4.1% of Akebia Therapeutics shares are held by company insiders. Comparatively, 29.1% of Wave Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk & volatility, AKBA or WVE? Akebia Therapeutics has a beta of 0.74, meaning that its stock price is 26% less volatile than the S&P 500. Comparatively, Wave Life Sciences has a beta of -1.2, meaning that its stock price is 220% less volatile than the S&P 500. Is AKBA or WVE more profitable? Akebia Therapeutics has a net margin of -27.07% compared to Wave Life Sciences' net margin of -66.50%. Akebia Therapeutics' return on equity of 0.00% beat Wave Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Akebia Therapeutics-27.07% N/A -20.57% Wave Life Sciences -66.50%-280.57%-52.90% Does the media prefer AKBA or WVE? In the previous week, Wave Life Sciences had 26 more articles in the media than Akebia Therapeutics. MarketBeat recorded 33 mentions for Wave Life Sciences and 7 mentions for Akebia Therapeutics. Wave Life Sciences' average media sentiment score of 0.47 beat Akebia Therapeutics' score of 0.14 indicating that Wave Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Akebia Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Wave Life Sciences 10 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate AKBA or WVE? Akebia Therapeutics presently has a consensus price target of $5.75, indicating a potential upside of 221.23%. Wave Life Sciences has a consensus price target of $21.89, indicating a potential upside of 60.12%. Given Akebia Therapeutics' higher probable upside, equities research analysts plainly believe Akebia Therapeutics is more favorable than Wave Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Akebia Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Wave Life Sciences 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, AKBA or WVE? Akebia Therapeutics has higher revenue and earnings than Wave Life Sciences. Wave Life Sciences is trading at a lower price-to-earnings ratio than Akebia Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAkebia Therapeutics$194.62M2.01-$51.92M-$0.23-7.78Wave Life Sciences$113.31M18.40-$57.51M-$1.11-12.32 SummaryAkebia Therapeutics beats Wave Life Sciences on 10 of the 18 factors compared between the two stocks. Ad WealthPressHow one pattern has averaged an 85% return per year since the pandemic. Over the last 5 years Roger Scott has done some pretty incredible things… He’s found hundreds of winning opportunities… He’s created some incredible strategies… And he’s even designed some amazing tools… But there is one thing he’s always kept close to the chest… And in this case, it’s been a very particular stock market pattern…. A pattern he calls the World's Most Predictable Pattern…Follow this link here and enter your email address to sign up… Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WVE vs. The Competition Export to ExcelMetricWave Life SciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.08B$6.39B$5.06B$8.67BDividend YieldN/A8.04%5.06%4.06%P/E Ratio-12.3210.1698.9217.12Price / Sales18.40266.571,205.7371.29Price / CashN/A53.4940.6936.36Price / Book14.709.306.325.87Net Income-$57.51M$154.14M$119.47M$225.66M7 Day Performance-16.85%-9.49%-5.11%-1.34%1 Month Performance-8.26%-7.23%-3.21%1.00%1 Year Performance149.00%30.70%32.41%25.27% Wave Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WVEWave Life Sciences4.8719 of 5 stars$13.67-8.9%$21.89+60.1%+149.0%$2.08B$113.31M-12.32240Analyst ForecastInsider SellingShort Interest ↑Analyst RevisionNews CoverageAKBAAkebia Therapeutics4.0582 of 5 stars$1.99+2.6%N/A+81.0%$407.96M$194.62M-8.65167URGNUroGen Pharma4.0705 of 5 stars$12.79+5.5%N/A-6.7%$299.93M$82.71M-4.06200RAPTRAPT Therapeutics4.5971 of 5 stars$1.75-39.4%N/A-91.6%$61.08M$1.53M-0.5680Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeMRNSMarinus Pharmaceuticals4.4479 of 5 stars$0.33-2.9%N/A-95.1%$18.44M$30.99M-0.13110Analyst ForecastShort Interest ↑Analyst RevisionNews CoverageCRNXCrinetics Pharmaceuticals3.5501 of 5 stars$60.01-1.1%N/A+93.1%$4.80B$4.01M-15.88210Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews CoverageASNDAscendis Pharma A/S3.06 of 5 stars$128.40+3.3%N/A+35.3%$7.79B$288.08M-13.79640Analyst DowngradeShort Interest ↑News CoverageGap DownLEGNLegend Biotech1.8575 of 5 stars$40.04+0.0%N/A-39.9%$7.30B$455.99M-51.331,800Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews CoverageELANElanco Animal Health3.5205 of 5 stars$14.27+1.4%N/A+21.5%$7.05B$4.42B35.669,300Short Interest ↑VKTXViking Therapeutics4.5098 of 5 stars$62.97-8.0%N/A+370.8%$7.02BN/A-67.7120CYTKCytokinetics4.0709 of 5 stars$58.62+1.1%N/A+58.5%$6.90B$7.53M-10.90250Insider Selling Related Companies and Tools Related Companies AKBA Alternatives URGN Alternatives RAPT Alternatives MRNS Alternatives CRNX Alternatives ASND Alternatives LEGN Alternatives ELAN Alternatives VKTX Alternatives CYTK Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:WVE) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wave Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Wave Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WVE Stock Alerts